About Ncgs
Ncgs is a company based in Charleston (United States) founded in 1984 was acquired by Novotech in May 2022. Ncgs operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others.
- Investors
- Acquired byNovotech
(May 2022)
Investors in Ncgs
Ncgs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novotech CRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of clinical research services across all trial phases and therapeutic areas | 2002 | novotech-cro.com | Sydney, Australia |
Investor details for Ncgs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ncgs
2 dated milestones of Ncgs across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Ncgs is founded.
- Exit Acquired by Novotech.
Competitors of Ncgs
Ncgs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helsinn.com | 1976 | Lugano, Switzerland | – | 103 | Oncology therapeutics are developed, manufactured, and commercialized by Helsinn. | |
| asterinsights.com | 2006 | Tampa, United States | $75M | 115 | Contract-based oncology clinical trial services are provided by Aster Insights. | |
| cancervax.com | 1998 | Carlsbad, United States | $58M | – | Cancer vaccine research and development is conducted by CancerVax. | |
| oncotherapeutics.com | 1988 | West Hollywood, United States | $8.3M | – | Preclinical and clinical oncology drug development services are provided. | |
| abogenbio.com | 2019 | Suzhou, China | $1.13B | – | mRNA-based therapeutics are developed for cancer and infectious diseases. | |
| oncusptx.com | 2021 | New York, United States | $100M | – | CRO offering clinical development services for oncology drugs | |
| linical.com | 2005 | Osaka, Japan | – | – | Full-service CRO operations are conducted across more than 20 countries. | |
| cmedresearch.com | 1999 | Horsham, United Kingdom | $10M | 225 | Full and functional clinical service offerings, while specializing in cloud-based clinical data solutions | |
| pangeabiomed.com | 2018 | Tel Aviv, Israel | $12M | – | Response prediction platform for dozens of cancer types is provided. | |
| bocabio.com | 2005 | Pompano Beach, United States | $25M | – | Oncology drug clinical development services are provided as a CRO. |
Detailed competitors of Ncgs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ncgs
Websites that share an audience with Ncgs (ncgs.com).
Websites whose visitors overlap most with Ncgs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
prainternational.com | prainternational.com | 100% | – | – | – |
| emissary.com | 100% | – | – | View details | |
| chiltern.com | 100% | – | – | View details | |
operatrix.com | operatrix.com | 100% | – | – | – |
ccsainc.com | ccsainc.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Ncgs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Ncgs
Complete news archive for Ncgs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ncgs
10 companies that operate in the same segment as Ncgs (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ncgs
Ncgs was founded in 1984.
Ncgs is headquartered in Charleston, United States. It is registered at Charleston, South Carolina, United States.
NCGS was founded in 1984 as a full-service contract research organization specializing in oncologyhematology, infectious disease, critical care, and CNS therapeutic areas. Involvement in the approval or expanded approval of 34 drug, biologic, diagnostic, and device products has been recorded, with no FDA warning letters or 483s noted. Operations are maintained across North America, Latin America, Europe, Asia Pacific, and Australia.
Ncgs has 1 investor. Key investors include Novotech CRO.
Yes. Ncgs was acquired by Novotech in May 2022.